BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2393885)

  • 1. [Type I and III membranoproliferative glomerulonephritis. Clinical picture and prognosis].
    Matousovic K; Rossmann P; Prát V; Chadimová M
    Cas Lek Cesk; 1990 Jun; 129(25):778-81. PubMed ID: 2393885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
    Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
    Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic membranous glomerulonephritis. Clinico-morphologic relations and prognosis].
    Matousovic K; Rossmann P; Prát V; Skibová J; Drevíkovská J
    Cas Lek Cesk; 1989 Oct; 128(43-44):1377-81. PubMed ID: 2598253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of clinical and morphologic changes in mesangiocapillary glomerulonephritis (MCGN) in reference to re-biopsy].
    Wagrowska-Danilewicz M; Danilewicz M
    Przegl Lek; 1994; 51(4):175-8. PubMed ID: 8058988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evolution of patients with isolated C3 mesangial glomerulonephritis.
    Calls Ginesta J; Almirall J; Torras A; Darnell A; Revert L
    Clin Nephrol; 1995 Apr; 43(4):221-5. PubMed ID: 7606875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K; Iskandar SS; Daeihagh P; Ratliff HL; Bleyer AJ
    Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pathology of the glomerulus--from phenomenon to entity. The mesangial lesion].
    Gärtner HV; Greschniok A; Wehrmann M; Bogenschütz O; Oliveira V; Mall A; Junghans R; Mikeler E; Bohle A
    Verh Dtsch Ges Pathol; 1989; 73():41-60. PubMed ID: 2482629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathologic features and prognosis of 21 children with isolated proteinuria].
    Dang XQ; Yi ZW; He XJ; Bai HT; Yang HB; Xu ZC
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):274-6. PubMed ID: 16706132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
    Taguchi T; Bohle A
    Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
    Arikan H; Koc M; Cakalagaoglu F; Tuglular S; Ozener C; Akoglu E
    Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors predicting chronic renal failure in membranoproliferative glomerulonephritis].
    Dobronravov VA
    Klin Med (Mosk); 1996; 74(7):29-33. PubMed ID: 8992108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
    Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
    Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
    Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
    Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranoproliferative glomerulonephritis type II in a 10-year-old girl.
    Tibbs ME; Andreoli SP; Phillips CL
    Clin Lab Sci; 2005; 18(2):84-9. PubMed ID: 15916240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseases.
    Gerstoft J; Balsløv JT; Brahm M; Brun C; Jørgensen F; Jørgensen HE; Larsen M; Larsen S; Lorenzen I; Løber M
    Acta Med Scand; 1986; 219(2):179-87. PubMed ID: 3962734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of membranoproliferative glomerulonephritis type II and pregnancy: a case report.
    Inaba S; Tanizawa T; Igarashi T; Higuchi A; Satou H; Mase D; Asada R; Suzuki Y; Okada T
    Clin Nephrol; 1989 Jul; 32(1):10-3. PubMed ID: 2758699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial membranoproliferative glomerulonephritis].
    Robles NR; Barquilla JF; Arrobas M; Campos de Orellana MC; González Ruiz C; Sánchez Casado E
    An Med Interna; 1998 Jul; 15(7):373-5. PubMed ID: 9710989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.